Thomas L. Gutshall

CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases

CEPHEID develops, manufactures and markets fully-integrated systems that perform genetic analysis. The firm's systems enable molecular testing for organisms and genetic-based diseases by automating otherwise complex manual laboratory procedures. The company was founded by Thomas L. Gutshall, William McMillan, Kurt Petersen, Greg Kovacs and M. Allen Northrup on March 4, 1996 and is headquartered in Sunnyvale, CA.

Metrika Inc. manufactures and markets disease-monitoring products. It also manufactures other chronic condition products. The company was founded in 1994 by Michael P. Allen and is headquartered in Sunnyvale, CA.

Satoris, Inc. develops tests for neurological diseases. It develops tests for neurological diseases such as Alzheimer's, Parkinson's, Multiple Sclerosis, and Diabetic Neuropathy. The company was founded in 2003 by Tony Wyss-Coray and Sandip Ray and is headquartered in Menlo Park, CA.

Profusa, Inc. provides biofeedback for chronic disease management and healthy livingg. It develops an in vivo human sensor system to generate real-time data on the levels of various body chemistries. Its first application being a glucose monitoring system. The company was founded by William McMillan, Kristen Lloyd Helton and Natalie Ann Wisniewski in 2009 and is headquartered in San Francisco, CA.

1Flourish Capital LLC (1Flourish Capital) is a venture capital firm founded in 2016 by David A. Lane, Reid Rutherford, Skip Vaccarello and Andrew Miller. The firm is headquartered in Mountain View, California.